RYOIX - Rydex Biotechnology Inv

Nasdaq - Nasdaq Delayed Price. Currency in USD

Overall Portfolio Composition (%)

Cash3.68%
Stocks94.09%
Bonds0.00%
Others2.23%
Preferred0.00%
Convertable0.00%

Sector Weightings (%)

Sector
RYOIX
Basic Materials
0.00%
Consumer Cyclical
0.00%
Financial Services
0.00%
Realestate
0.00%
Consumer Defensive
0.00%
Healthcare
100.00%
Utilities
0.00%
Communication Services
0.00%
Energy
0.00%
Industrials
0.00%
Technology
0.00%

Equity Holdings

AverageRYOIXCategory Average
Price/Earnings16.2715.82
Price/Book4.294.22
Price/Sales5.342.96
Price/Cashflow13.3511.19
Median Market Cap12,662.8429,190.74
3 Year Earnings Growth05.26

Bond Holdings

AverageRYOIXCategory Average
MaturityN/AN/A
DurationN/AN/A
Credit QualityN/AN/A

Bond Ratings

SectorRYOIX
US Goverment0.00%
AAA0.00%
AA0.00%
A0.00%
BBB0.00%
BB0.00%
B0.00%
Below B0.00%
Others0.00%

Top 10 Holdings (38.55% of Total Assets)

Get Quotes for Top Holdings
NameSymbol% Assets
AbbVie IncABBV5.74%
Amgen IncAMGN5.51%
Gilead Sciences IncGILD5.05%
Celgene CorpCELG4.23%
Biogen IncBIIB3.92%
Vertex Pharmaceuticals IncVRTX3.25%
Regeneron Pharmaceuticals IncREGN3.22%
Illumina IncILMN3.02%
Alexion Pharmaceuticals IncALXN2.46%
Nektar Therapeutics IncNKTR2.15%